Synchronous tumours of the female genital tract: REVIEW

Histopathology

Volumn 56, Issue 3, 2010, Pages 277-285

  Singh, Naveena ^a  

^a BARTS HEALTH NHS TRUST   (United Kingdom)

Author keywords

Endometrial neoplasia; Ovarian neoplasia; Pathology; Synchronous

Indexed keywords

ANTINEOPLASTIC AGENT; ANTINEOPLASTIC METAL COMPLEX; BETA CATENIN; PHOSPHATIDYLINOSITOL 3,4,5 TRISPHOSPHATE 3 PHOSPHATASE;

ACCURACY; CANCER CHEMOTHERAPY; CANCER CLASSIFICATION; CANCER DIAGNOSIS; CANCER INCIDENCE; CANCER PATIENT; CANCER RADIOTHERAPY; CANCER STAGING; CLINICAL FEATURE; COLON CANCER; DIAGNOSTIC PROCEDURE; ENDOMETRIUM CANCER; FAMILIAL CANCER; FEMALE GENITAL TRACT TUMOR; GENE EXPRESSION; GENE EXPRESSION PROFILING; GENE MUTATION; GENETIC ANALYSIS; GENETIC PROCEDURES; GYNECOLOGIC CANCER; HETEROZYGOSITY; HISTOPATHOLOGY; HUMAN; IMMUNOHISTOCHEMISTRY; MEDICAL INFORMATION; METASTASIS; MICROSATELLITE INSTABILITY; MISMATCH REPAIR; OVARY CANCER; OVARY METASTASIS; PATHOGENESIS; PATIENT CARE; PERITONEUM CANCER; PRIMARY TUMOR; PRIORITY JOURNAL; REVIEW; RISK FACTOR; STANDARD; UTERINE CERVIX CANCER; UTERINE TUBE;

FEMALE; GENITAL NEOPLASMS, FEMALE; HUMANS; NEOPLASMS, MULTIPLE PRIMARY;

EID: 77449120019     PISSN: 03090167     EISSN: 13652559     Source Type: Journal    
DOI: 10.1111/j.1365-2559.2009.03367.x     Document Type: Review

References (76)

1. Ayhan A, Yalcin OT, Tuncer ZS, Gurgan T, Kucukali T. Synchronous primary malignancies of the female genital tract. Eur. J. Obstet. Gynecol. Reprod. Biol. 1992 45 63 66.
2. Eisner RF, Nieberg RK, Berek JS. Synchronous primary neoplasms of the female reproductive tract. Gynecol. Oncol. 1989 33 335 339.
3. Tong SY, Lee YS, Park JS, Bae SN, Lee JM, Namkoong SE. Clinical analysis of synchronous primary neoplasms of the female reproductive tract. Eur. J. Obstet. Gynecol. Reprod. Biol. 2008 136 78 82.
4. Amalinei C. [Morphogenesis and differentiation of the female genital tract Genetic determinism and epithelium-stromal interactions]. Rev. Med. Chir. Soc. Med. Nat. Iasi 2007 111 200 209.
5. Dubeau L. The cell of origin of ovarian epithelial tumours. Lancet Oncol. 2008 9 1191 1197.
6. Soliman PT, Slomovitz BM, Broaddus RR et al. Synchronous primary cancers of the endometrium and ovary: A single institution review of 84 cases. Gynecol. Oncol. 2004 94 456 462.
7. Soliman PT, Oh JC, Schmeler KM et al. Risk factors for young premenopausal women with endometrial cancer. Obstet. Gynecol. 2005 105 575 580.
8. Walsh C, Holschneider C, Hoang Y, Tieu K, Karlan B, Cass I. Coexisting ovarian malignancy in young women with endometrial cancer. Obstet. Gynecol. 2005 106 693 699.
9. Pearl ML, Johnston CM, Frank TS, Roberts JA. Synchronous dual primary ovarian and endometrial carcinomas. Int. J. Gynaecol. Obstet. 1993 43 305 312.
10. Falkenberry SS, Steinhoff MM, Gordinier M, Rappoport S, Gajewski W, Granai CO. Synchronous endometrioid tumors of the ovary and endometrium. A clinicopathologic study of 22 cases. J. Reprod. Med. 1996 41 713 718.
11. Nishimura N, Hachisuga T, Nabeshima K, Kawarabayashi T. Synchronous endometrial and ovarian carcinomas: analysis of genetic relationship of the tumors. Int. J. Oncol. 2005 27 1519 1526.
12. Natee J, Kietpeerakool C, Srisomboon J et al. Clinicopathologic analysis of women with synchronous primary carcinomas of the endometrium and ovary: 10-year experience from Chiang Mai University Hospital. Asian Pac. J. Cancer Prev. 2006 7 234 238.
13. Lou HM, Lou HK, Wu MJ. [Synchronous primary cancer of the endometrium and ovary]. Zhonghua zhong liu za zhi [Chinese journal of oncology] 2006 28 617 620.
14. Ayhan A, Guvenal T, Coskun F, Basaran M, Salman MC. Survival and prognostic factors in patients with synchronous ovarian and endometrial cancers and endometrial cancers metastatic to the ovaries. Eur. J. Gynaecol. Oncol. 2003 24 171 174.
15. Zaino R, Whitney C, Brady MF, DeGeest K, Burger RA, Buller RE. Simultaneously detected endometrial and ovarian carcinomas - a prospective clinicopathologic study of 74 cases: a Gynecologic Oncology Group study. Gynecol. Oncol. 2001 83 355 362.
16. Ulbright TM, Roth LM. Metastatic and independent cancers of the endometrium and ovary: a clinicopathologic study of 34 cases. Hum. Pathol. 1985 16 28 34.
17. Scully RE, Young RH, Clement PB. Tumors of the ovary, maldeveloped gonads, fallopian tube and broad ligament. Atlas of tumor pathology. Bethesda, MD : Armed Forces Institute of Pathology, 1998.
18. Symonds DA, Johnson DP, Wheeless CR Jr. Feulgen cytometry in simultaneous endometrial and ovarian carcinoma. Cancer 1988 61 2511 2516.
19. Vassilev NB, Christov KT, Raychev RD. Ovarian and endometrial endometrioid carcinoma: diagnostic implications of flow cytometry. Neoplasma 1986 33 57 62.
20. Prat J, Matias-Guiu X, Barreto J. Simultaneous carcinoma involving the endometrium and the ovary. A clinicopathologic, immunohistochemical, and DNA flow cytometric study of 18 cases. Cancer 1991 68 2455 2459.
21. Fujita M, Enomoto T, Wada H, Inoue M, Okudaira Y, Shroyer KR. Application of clonal analysis. Differential diagnosis for synchronous primary ovarian and endometrial cancers and metastatic cancer. Am. J. Clin. Pathol. 1996 105 350 359.
22. Shenson DL, Gallion HH, Powell DE, Pieretti M. Loss of heterozygosity and genomic instability in synchronous endometrioid tumors of the ovary and endometrium. Cancer 1995 76 650 657.
23. Emmert-Buck MR, Chuaqui R, Zhuang Z, Nogales F, Liotta LA, Merino MJ. Molecular analysis of synchronous uterine and ovarian endometrioid tumors. Int. J. Gynecol. Pathol. 1997 16 143 148.
24. Ramus SJ, Elmasry K, Luo Z et al. Predicting clinical outcome in patients diagnosed with synchronous ovarian and endometrial cancer. Clin. Cancer Res. 2008 14 5840 5848.
25. Lin WM, Forgacs E, Warshal DP et al. Loss of heterozygosity and mutational analysis of the PTEN/MMAC1 gene in synchronous endometrial and ovarian carcinomas. Clin. Cancer Res. 1998 4 2577 2583.
26. Matias-Guiu X, Lagarda H, Catasus L et al. Clonality analysis in synchronous or metachronous tumors of the female genital tract. Int. J. Gynecol. Pathol. 2002 21 205 211.
27. Moreno-Bueno G, Gamallo C, Perez-Gallego L, de MoraJC, Suarez A, Palacios J. beta-Catenin expression pattern, beta-catenin gene mutations, and microsatellite instability in endometrioid ovarian carcinomas and synchronous endometrial carcinomas. Diagn. Mol. Pathol. 2001 10 116 122.
28. Fujii H, Matsumoto T, Yoshida M et al. Genetics of synchronous uterine and ovarian endometrioid carcinoma: combined analyses of loss of heterozygosity, PTEN mutation, and microsatellite instability. Hum. Pathol. 2002 33 421 428.
29. Ricci R, Komminoth P, Bannwart F et al. PTEN as a molecular marker to distinguish metastatic from primary synchronous endometrioid carcinomas of the ovary and uterus. Diagn. Mol. Pathol. 2003 12 71 78.
30. Kaneki E, Oda Y, Ohishi Y et al. Frequent microsatellite instability in synchronous ovarian and endometrial adenocarcinoma and its usefulness for differential diagnosis. Hum. Pathol. 2004 35 1484 1493.
31. Irving JA, Catasus L, Gallardo A et al. Synchronous endometrioid carcinomas of the uterine corpus and ovary: alterations in the beta-catenin (CTNNB1) pathway are associated with independent primary tumors and favorable prognosis. Hum. Pathol. 2005 36 605 619.
32. Ramus SJE, Zhiyuan K, Gammerman L et al. Predicting clinical outcome in patients diagnosed with synchronous ovarian and endometrial cancer. Clin. Cancer 2008 14 5840 5848.
33. Guirguis A, Elishaev E, Oh SH, Tseng GC, Zorn K, DeLoia JA. Use of gene expression profiles to stage concurrent endometrioid tumors of the endometrium and ovary. Gynecol. Oncol. 2008 108 370 376.
34. Catasus L, Bussaglia E, Rodrguez I et al. Molecular genetic alterations in endometrioid carcinomas of the ovary: similar frequency of beta-catenin abnormalities but lower rate of microsatellite instability and PTEN alterations than in uterine endometrioid carcinomas. Hum. Pathol. 2004 35 1360 1368.
35. Chang KH, Albarracin C, Luthra R et al. Discordant genetic changes in ovarian and endometrial endometrioid carcinomas: a potential pitfall in molecular diagnosis. Int. J. Gynecol. Cancer 2006 16 178 182.
36. Prat J. Clonality analysis in synchronous tumors of the female genital tract. Hum. Pathol. 2002 33 383 385. (Pubitemid 34627587)
37. Zaino RJ, Unger ER, Whitney C. Synchronous carcinomas of the uterine corpus and ovary. Gynecol. Oncol. 1984 19 329 335.
38. Nishimura N, Hachisuga T, Yokoyama M, Iwasaka T, Kawarabayashi T. Clinicopathologic analysis of the prognostic factors in women with coexistence of endometrioid adenocarcinoma in the endometrium and ovary. J. Obstet. Gynaecol. Res. 2005 31 120 126.
39. Choo YC, Naylor B. Multiple primary neoplasms of the ovary and uterus. Int. J. Gynaecol. Obstet. 1982 20 327 334.
40. Shen K. [Double primary carcinoma of the uterine corpus and ovary]. Zhonghua fu chan ke za zhi 1993 28 227 229.
41. Chen F, Shen K, Lang JH, Huang HF, Wu M. [Clinical features and prognostic of double primary carcinoma of uterine corpus and the ovary]. Zhonghua yi xue za zhi 2005 85 1257 1260.
42. Shen J, Song HJ, Liu TH. [Synchronous primary cancers of endometrium and ovary]. Zhonghua fu chan ke za zhi 1994 29 498 501.
43. Sheu BC, Lin HH, Chen CK, Chao KH, Shun CT, Huang SC. Synchronous primary carcinomas of the endometrium and ovary. Int. J. Gynaecol. Obstet. 1995 51 141 146.
44. Drake AC, Campbell H, Porteous ME, Dunlop MG. The contribution of DNA mismatch repair gene defects to the burden of gynecological cancer. Int. J. Gynecol. Cancer 2003 13 262 277.
45. Soliman PT, Broaddus RR, Schmeler KM et al. Women with synchronous primary cancers of the endometrium and ovary: do they have Lynch syndrome? J. Clin. Oncol. 2005 23 9344 9350.
46. Shannon C, Kirk J, Barnetson R et al. Incidence of microsatellite instability in synchronous tumors of the ovary and endometrium. Clin. Cancer Res. 2003 9 1387 1392.
47. Culton LK, Deavers MT, Silva EG, Liu J, Malpica A. Endometrioid carcinoma simultaneously involving the uterus and the fallopian tube: a clinicopathologic study of 13 cases. Am. J. Surg. Pathol. 2006 30 844 849.
48. Lax SF. Molecular genetic pathways in various types of endometrial carcinoma: from a phenotypical to a molecular-based classification. Virchows Arch. 2004 444 213 223.
49. Kurman RJ, Shih Ie M. Pathogenesis of ovarian cancer: lessons from morphology and molecular biology and their clinical implications. Int. J. Gynecol. Pathol. 2008 27 151 160.
50. Santin AD, Zhan F, Bellone S et al. Discrimination between uterine serous papillary carcinomas and ovarian serous papillary tumours by gene expression profiling. Br. J. Cancer 2004 90 1814 1824.
51. McCluggage WG. WT1 is of value in ascertaining the site of origin of serous carcinomas within the female genital tract. Int. J. Gynecol. Pathol. 2004 23 97 99.
52. Levenback C, Burke TW, Silva E et al. Uterine papillary serous carcinoma (UPSC) treated with cisplatin, doxorubicin, and cyclophosphamide (PAC). Gynecol. Oncol. 1992 46 317 321.
53. Carcangiu ML, Chambers JT. Uterine papillary serous carcinoma: a study on 108 cases with emphasis on the prognostic significance of associated endometrioid carcinoma, absence of invasion, and concomitant ovarian carcinoma. Gynecol. Oncol. 1992 47 298 305.
54. Nicklin JL, Copeland LJ. Endometrial papillary serous carcinoma: patterns of spread and treatment. Clin. Obstet. Gynecol. 1996 39 686 695.
55. Wheeler DT, Bell KA, Kurman RJ, Sherman ME. Minimal uterine serous carcinoma: diagnosis and clinicopathologic correlation. Am. J. Surg. Pathol. 2000 24 797 806.
56. Euscher ED, Malpica A, Deavers MT, Silva EG. Differential expression of WT-1 in serous carcinomas in the peritoneum with or without associated serous carcinoma in endometrial polyps. Am. J. Surg. Pathol. 2005 29 1074 1078.
57. Moll UM, Valea F, Chumas J. Role of p53 alteration in primary peritoneal carcinoma. Int. J. Gynecol. Pathol. 1997 16 156 162.
58. Soslow RA, Pirog E, Isacson C. Endometrial intraepithelial carcinoma with associated peritoneal carcinomatosis. Am. J. Surg. Pathol. 2000 24 726 732.
59. Halperin R, Zehavi S, Hadas E, Habler L, Bukovsky I, Schneider D. Immunohistochemical comparison of primary peritoneal and primary ovarian serous papillary carcinoma. Int. J. Gynecol. Pathol. 2001 20 341 345. (Pubitemid 32937448)
60. Chen LM, Yamada SD, Fu YS, Baldwin RL, Karlan BY. Molecular similarities between primary peritoneal and primary ovarian carcinomas. Int. J. Gynecol. Cancer 2003 13 749 755.
61. Muto MG, Welch WR, Mok SC et al. Evidence for a multifocal origin of papillary serous carcinoma of the peritoneum. Cancer Res. 1995 55 490 492.
62. Nishimura M, Wakabayashi M, Hashimoto T et al. Papillary serous carcinoma of the peritoneum: analysis of clonality of peritoneal tumors. J. Gastroenterol. 2000 35 540 547.
63. Cass I, Baldwin RL, Fasylova E et al. Allelotype of papillary serous peritoneal carcinomas. Gynecol. Oncol. 2001 82 69 76.
64. Singh N, Arif S. Histopathologic parameters of prognosis in cervical cancer - a review. Int. J. Gynecol. Cancer 2004 14 741 750.
65. Yemelyanova AV, Vang R, Judson K, Wu LS, Ronnett BM. Distinction of primary and metastatic mucinous tumors involving the ovary: analysis of size and laterality data by primary site with reevaluation of an algorithm for tumor classification. Am. J. Surg. Pathol. 2008 32 128 138.
66. Elishaev E, Gilks CB, Miller D, Srodon M, Kurman RJ, Ronnett BM. Synchronous and metachronous endocervical and ovarian neoplasms: evidence supporting interpretation of the ovarian neoplasms as metastatic endocervical adenocarcinomas simulating primary ovarian surface epithelial neoplasms. Am. J. Surg. Pathol. 2005 29 281 294.
67. Ronnett BM, Yemelyanova AV, Vang R et al. Endocervical adenocarcinomas with ovarian metastases: analysis of 29 cases with emphasis on minimally invasive cervical tumors and the ability of the metastases to simulate primary ovarian neoplasms. Am. J. Surg. Pathol. 2008 32 1835 1853.
68. Leake JF, Woodruff JD, Searle C, Daniel R, Shah KV, Currie JL. Human papillomavirus and epithelial ovarian neoplasia. Gynecol. Oncol. 1989 34 268 273.
69. Anttila M, Syrjanen S, Ji H, Saarikoski S, Syrjanen K. Failure to demonstrate human papillomavirus DNA in epithelial ovarian cancer by general primer PCR. Gynecol. Oncol. 1999 72 337 341.
70. Trottier AM, Provencher D, Mes-Masson AM, Vauclair R, Coutlee F. Absence of human papillomavirus sequences in ovarian pathologies. J. Clin. Microbiol. 1995 33 1011 1013.
71. Reichert RA. Synchronous and metachronous endocervical and ovarian neoplasms: a different interpretation of HPV data. Am. J. Surg. Pathol. 2005 29 1686 1687 author's reply 7-9.
72. Vang R, Gown AM, Farinola M et al. p16 expression in primary ovarian mucinous and endometrioid tumors and metastatic adenocarcinomas in the ovary: utility for identification of metastatic HPV-related endocervical adenocarcinomas. Am. J. Surg. Pathol. 2007 31 653 663.
73. Sieben NL, Roemen GM, Oosting J, Fleuren GJ, van Engeland M, Prat J. Clonal analysis favours a monoclonal origin for serous borderline tumours with peritoneal implants. J. Pathol. 2006 210 405 411.
74. Sieben NL, Kolkman-Uljee SM, Flanagan AM et al. Molecular genetic evidence for monoclonal origin of bilateral ovarian serous borderline tumors. Am. J. Pathol. 2003 162 1095 1101.
75. Diebold J, Seemuller F, Lohrs U. K-RAS mutations in ovarian and extraovarian lesions of serous tumors of borderline malignancy. Lab. Invest. 2003 83 251 258.
76. Mayr D, Hirschmann A, Lohrs U, Diebold J. KRAS and BRAF mutations in ovarian tumors: a comprehensive study of invasive carcinomas, borderline tumors and extraovarian implants. Gynecol. Oncol. 2006 103 883 887.